Objective:To analyze the relationship between peripheral blood T lymphocyte subsets, cell surface programmed death receptor 1 (PD-1) and prognosis in patients with gastric cancer. Methods:Seventy-five patients with gastric cancer were selected as gastric cancer group, and 30 healthy people undergoing physical examination in our hospital were served as control group. The relationship between the changes of CD3+, CD4+, CD8+, CD4+/CD8+ ratio and PD-1 levels in peripheral blood T lymphocytes and the prognosis of gastric cancer patients was analyzed. Results:The levels of CD8+ and PD-1 in peripheral blood T lymphocytes of the gastric cancer group were significantly higher than those in the control group, while the levels of CD3+, CD4+ and CD4+/CD8+ were significantly lower than those of the control group (P<0.05). CD8+ and PD-1 expressions in peripheral blood T lymphocyte of the death group were significantly higher than those in the survival group, while the levels of CD3+,CD4+ and CD4+/CD8+ ratio were significantly lower than those in the survival group (P<0.05). Multiariable COX regression analysis showed that the levels of CD3+, CD4+, CD8+, CD4+/CD8+ ratio in peripheral blood, PD-1, age and tumor stage were independent risk factors for prognosis in patients with gastric cancer. The levels of CD8+ and PD-1 were positively correlated with the prognosis of patients with gastric cancer while the levels of CD3+, CD4+, CD4+/CD8+ were negatively correlated with the prognosis. Conclusion:CD8+ and PD-1 expressions in T lymphocyte subsets are significantly increased in patients with gastric cancer. Combined detection of the levels of PD-1 and T lymphocyte subsets can effectively assist doctors to assess patients with gastric cancer, which is worth clinical application. |
[1] 王展梅,曹芳丽,曲琳莉,等.外周血T淋巴细胞亚群检测在胃癌病情监测及预后评价中的意义[J].癌症进展,2016,14(4):369-371,374.
[2] PEIXOTO R D,de SOUSA T T,SILVA P,et al.Complete response for more than 4 years following neoadjuvant FOLFOX and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for a patient with advanced gastric cancer with extensive peritoneal carcinomatosis[J].Case Rep Oncol,2018,11(2):305-310.
[3] SHI J,CHENG C,MA J,et al.Gene expression signature for detection of gastric cancer in peripheral blood[J].Oncol Lett,2018,15(6):9802-9810.
[4] 骆飞,孙昭,白春梅.PD-1/PD-L1在胃癌中的研究进展[J].癌症进展,2016,14(6):503-506.
[5] 吴圣,邵婧怡,王芳,等.PD-L1和PD-1在胃癌组织中的表达及其临床意义[J].安徽医科大学学报,2015,50(6):821-825.
[6] 李浩,李松岩,胡时栋,等.胃腺癌患者外周血PD-1+淋巴细胞和CD4+CD25+FOXP3+T细胞增加[J].细胞与分子免疫学杂志,2017,33(1):81-84,88.
[7] 戴滋瀛,关泉林.PD-1/PD-L1在肿瘤治疗中的进展[J].世界华人消化杂志,2017,25(14):1231-1239.
[8] 黄旭宏,宋玉国,刘春雷,等.胃癌及癌前病变患者外周血T淋巴细胞亚群的表达及意义[J].北华大学学报(自然科学版),2017,18(6):759-761.
[9] 陈耀平,屈蕾,陈静,等.胃癌患者外周血CD8+CD28+与CD8+CD57+T细胞亚群的变化及临床意义[J].宁夏医科大学学报,2017,39(9):1003-1005,1011.
[10] IWAMOTO K,TAKAHASHI H,HARAGUCHI N et al.Laparoscopic surgery for sigmoid colon cancer after multiple operations including urinary diversion with Indiana pouch:a case report[J].Asian J Endosc Surg,2017,10(4):420-423.
[11] 宋振宇.外周血T淋巴细胞亚群与免疫球蛋白检测在胃癌病情监测及预后评价中的价值[J].实用癌症杂志,2015,30(8):1126-1128.
[12] 徐本玲,袁龙,袁鹏,等.胃癌患者外周及肿瘤组织中CD4+T淋巴细胞上Tim-3的表达及其临床意义[J].实用医学杂志,2017,33(1):108-112.
[13] 张风宾,乔静雪,王英南,等.PD-1/PD-L1在胃癌组织中的表达及其临床意义[J].中国肿瘤生物治疗杂志,2018,25(2):170-176.
[14] NAKAUCHI M,SUDA K,NAKAMURA K et al.Laparoscopic subtotal gastrectomy for advanced gastric cancer:technical aspects and surgical,nutritional and oncological outcomes[J].Surg Endosc,2017,31(11):4631-4640.
[15] 何芳,王芳,张艳婷,等.胃癌患者CD4+和CD8+T细胞的PD-1高表达与肿瘤免疫逃逸的关系[J].中国老年学杂志,2017,37(22):5505-5507. |